Crossmark

Assessing causality by means of the Naranjo scale in a paediatric patient with life threatening respiratory failure after alemtuzumab administration: a case report

Crossref DOI link: https://doi.org/10.1186/s12887-021-02698-w

Published Online: 2021-05-12

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Smeets, Nori J. L. http://orcid.org/0000-0002-4927-2459
Eijk, Ruud J. R.

de Wildt, Saskia N.

Bootsma-Robroeks, Charlotte M. H. H. T.
License Information

Text and Data Mining valid from 2021-05-12

Version of Record valid from 2021-05-12
More Information

Article History

Received: 28 January 2021

Accepted: 4 May 2021

First Online: 12 May 2021

Declarations

:

: Not applicable.

: The patient and his parents gave permission to publish this work, no institutional review board approval was obtained. Written informed consent of the patient and his parents was obtained and is available upon request.

: The authors declare no conflicts of interest.

Document is current

Any future updates will be listed below